Alumni

Jaime Eberle Ph.D.

Jaime received her BS in Neuroscience from SUNY Binghamton in 2010. During this time she completed her honors thesis in the Deak Lab, where she studied the neuroimmunological consequences of chronic social stress in rats using a social defeat paradigm. Following her graduation, she pursued additional research training at the National Cancer Institute in the Pastan Lab, where she helped identify and eliminate T cell epitopes in a recombinant immunotoxin to improve its utility as a cancer therapeutic. In 2012, Jaime began her PhD studies at Columbia University. Her interest in translational research led her to join the Olive Lab, where she is currently using the KPC mouse model of pancreatic cancer to study the molecular mechanisms underlying this disease. Jaime successfully defended her Ph.D. and will be attending Thomas Jefferson University Medical School in the fall.

Carlo Maurer, M.D.

Carlo started an experimental MD thesis at the Institut für Biochemie und Molekularbiologie in Freiburg (Germany) in 2007 when he was still a medical student. Under the supervision of Matthias Müller he studied mechanistic aspects that underlie the translocation of folded proteins across the inner membrane of E. coli. After receiving his MD degree in 2011, he pursued clinical training in the Department of Gastroenterology and Hepatology at the Klinikum rechts der Isar (TU München) in Munich (Germany). Besides his clinical training, he characterized the effects of IL-8 signaling and telomere attrition in a GEMM of Barrett’s esophagus in the laboratory of Michael Quante. During his care for patients with GI cancers, his attention was drawn towards the giant clinical problem that is pancreatic cancer. This led him to join the Olive laboratory where he currently studies differential gene expression in pancreatic cancer and is supported by a Mildred-Scheel Postdoctoral Fellowship (Deutsche Krebshilfe).

Roshan Ahmed, Ph.D.

Roshan received her B.A. in the Biological Sciences and the History and Philosophy of Science and Medicine from the University of Chicago in 2008. Soon after graduation she started research in Dr. Joanna Burdette's laboratory at the University of Illinois at Chicago on p53 and Smad signaling in ovarian cancer. This experience sparked her interest in basic science and after two years in the Burdette laboratory, Roshan joined the Pharmacology and Molecular Signaling PhD program at Columbia University. To continue her work on cancer biology and gain experience in translational research, Roshan began work in the Olive lab in 2012. Roshan’s research focuses on targeting pancreatic cancer metabolism, in particular understanding the contribution of de novo fatty acid synthesis and scavenging to tumor growth and maintenance. Roshan successfully defended her Ph.D. in the spring of 2018.